Panitumumab-IRDye800

· Amgen; Li-Cor Biosciences

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Panitumumab-IRDye800, covering 2022-11-10 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures [EARLY_Phase 1]

See pricing